AIZ
82
2
AVGO
18
-9
CSX
57
-4
PCAR
56
-5
DOV
65
-4
MTB
65
-2
ILMN
32
-9
PFE
14
-7
ECL
55
-2
V
64
-2
BEN
50
9
LMT
30
-2
EIX
70
3
HUM
41
-4
BA
47
2
KLAC
38
-6
TMO
42
-6
XEL
67
2
SYF
86
-6
NWS
75
-4
AIZ
82
2
AVGO
18
-9
CSX
57
-4
PCAR
56
-5
DOV
65
-4
MTB
65
-2
ILMN
32
-9
PFE
14
-7
ECL
55
-2
V
64
-2
BEN
50
9
LMT
30
-2
EIX
70
3
HUM
41
-4
BA
47
2
KLAC
38
-6
TMO
42
-6
XEL
67
2
SYF
86
-6
NWS
75
-4
Financhill
Back

Clearside Biomedical Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
20

CLSD
Clearside Biomedical

Last Price:
0.99
Seasonality Move:
25.1%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
20
Clearside Biomedical (CLSD) is a Sell

Is Clearside Biomedical a Buy, Sell or Hold?

  • The current Clearside Biomedical [CLSD] share price is $0.99. The Score for CLSD is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • CLSD is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CLSD Stock Price Chart

What is Clearside Biomedical's stock price today?

  • The Clearside Biomedical share price today is $0.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLSD is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

CLSD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 38.1 Sell
Chaikin Money Flow: -295473 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.04 - 1.18) Sell
Bollinger Bands (100): (1.03 - 1.27) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

CLSD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.08 Sell
20-day SMA: 1.09 Sell
50-day SMA: 1.19 Sell
200-day SMA: 1.26 Sell
8-day EMA: 1.06 Sell
20-day EMA: 1.1 Sell
50-day EMA: 1.14 Sell
200-day EMA: 1.19 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Clearside Biomedical Earnings Growth & CLSD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.02 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Clearside Biomedical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):